Evidence map›Paper›PMID 30314751›Full record

ReviewJournal of cataract and refractive surgery2018

Transepithelial versus epithelium-off corneal crosslinking for corneal ectasia.

Hidenaga Kobashi, Shi Song Rong, Joseph B Ciolino

Abstract readReview
In one paragraph

Review in Journal of cataract and refractive surgery, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Transepithelial corneal cross-linking: a review.International ophthalmology · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Hidenaga KobashiFrom the Schepens Eye Research Institute (Kobashi), Department of Ophthalmology, Harvard Medical School, Boston, and the Massachusetts Eye and Ear Infirmary (Rong, Ciolino), Harvard Medical School, Boston, Massachusetts, USA the Department of Ophthalmology (Kobashi), Keio University, School of Medicine, Tokyo, Japan. Electronic address: hidenaga_kobashi@keio.jp.
Shi Song RongFrom the Schepens Eye Research Institute (Kobashi), Department of Ophthalmology, Harvard Medical School, Boston, and the Massachusetts Eye and Ear Infirmary (Rong, Ciolino), Harvard Medical School, Boston, Massachusetts, USA the Department of Ophthalmology (Kobashi), Keio University, School of Medicine, Tokyo, Japan.
Joseph B CiolinoFrom the Schepens Eye Research Institute (Kobashi), Department of Ophthalmology, Harvard Medical School, Boston, and the Massachusetts Eye and Ear Infirmary (Rong, Ciolino), Harvard Medical School, Boston, Massachusetts, USA the Department of Ophthalmology (Kobashi), Keio University, School of Medicine, Tokyo, Japan.

Funding

Antibiotic eluting contact lenses for the treatment of bacterial keratitisR01EY026640 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI CIOLINO, JOSEPH B. · 2017 to 2020
$2.0M
NEI NIH HHS R01 EY026640
6 · The paper itself

Abstract

This review compared the clinical results of transepithelial corneal crosslinking (CXL) to epithelium-off (epi-off) CXL in progressive corneal ectasia using a metaanalysis. The Cochrane databases and Medline were searched for randomized controlled trials (RCTs). Seven RCTs involving 505 eyes that met the eligibility criteria were identified. The epi-off CXL group showed significantly better outcomes in postoperative changes in maximum keratometry (K) during 1-year observation periods. Transepithelial CXL resulted in significantly greater post-treatment central corneal thickness and best spectacle-corrected visual acuity (BSCVA). The presence of a postoperative demarcation line was significantly more frequent after epi-off CXL than that after transepithelial CXL. No statistically significant difference was found between other parameters. Although patients in the transepithelial CXL group demonstrated a greater improvement in BSCVA compared with patients in the epi-off CXL group at the 1 year follow-up, transepithelial CXL had less impact on halting progressive corneal ectasia in terms of maximum K than epi-off CXL.

Indexed as

CollagenCorneal DiseasesCorneal TopographyCross-Linking ReagentsDilatation, PathologicEpithelium, CornealHumansPhotochemotherapyPhotosensitizing AgentsRiboflavinCollagenCross-Linking ReagentsPhotosensitizing AgentsRiboflavin

Identifiers

PMID30314751
PMCPMC8561077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.